These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 1950028

  • 1. [Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism].
    Simon B, Bergdolt H, Dammann H, Müller P.
    Z Gastroenterol; 1991 May; 29(5):217-21. PubMed ID: 1950028
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of non-steroidal anti-inflammatory drug-induced damage to gastric mucosa using ranitidine. Comparison of the effectiveness of 2 dosages].
    Müller P, Dammann HG, Marinis E, Weise D, Simon B.
    Fortschr Med; 1989 Oct 30; 107(31):667-70. PubMed ID: 2687142
    [Abstract] [Full Text] [Related]

  • 3. [Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients].
    Simon B, Leucht U, Amon I, Brandau J, Müller P.
    Z Gastroenterol; 1993 Jun 30; 31(6):395-400. PubMed ID: 8212757
    [Abstract] [Full Text] [Related]

  • 4. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases].
    Simon B, Beckers KH, Biewer W, Bouzo MH, Dammann HG, Gebest HJ, Müller P, Schütz E.
    Z Gastroenterol; 1988 Jun 30; 26(6):310-3. PubMed ID: 3061183
    [Abstract] [Full Text] [Related]

  • 5. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis.
    Saggioro A, Alvisi V, Blasi A, Dobrilla G, Fioravanti A, Marcolongo R.
    Ital J Gastroenterol; 1991 Jun 30; 23(3):119-23. PubMed ID: 1742504
    [Abstract] [Full Text] [Related]

  • 6. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs].
    Stock KP, Bach GL.
    Z Rheumatol; 1988 Jun 30; 47(3):177-81. PubMed ID: 3213266
    [Abstract] [Full Text] [Related]

  • 7. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G, Lazzaroni M, Petrillo M.
    Am J Gastroenterol; 1997 Apr 30; 92(4):663-7. PubMed ID: 9128319
    [Abstract] [Full Text] [Related]

  • 8. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG.
    Am J Gastroenterol; 1996 Feb 30; 91(2):223-7. PubMed ID: 8607484
    [Abstract] [Full Text] [Related]

  • 9. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ, Agrawal NM.
    J Physiol Pharmacol; 1995 Mar 30; 46(1):3-16. PubMed ID: 7599335
    [Abstract] [Full Text] [Related]

  • 10. [NSAID-induced ulcers--therapy and prevention].
    Rösch W.
    Z Rheumatol; 1995 Mar 30; 54(1):2-8; discussion 9-11. PubMed ID: 7725807
    [Abstract] [Full Text] [Related]

  • 11. [Antisecretory drugs and prophylaxis of secondary gastrointestinal effects associated with the consumption of non steroid anti-inflammatory drugs].
    Lanas A, Arroyo MT.
    Med Clin (Barc); 2000 Mar 30; 114 Suppl 2():57-62. PubMed ID: 10916808
    [Abstract] [Full Text] [Related]

  • 12. [Gastroduodenal lesions in rheumatoid arthritis. Evaluation and treatment].
    Martínez RO, Casas H, Mazure PA, Leczycki H, Cosen JN, Canievsky L, Abib A.
    Acta Gastroenterol Latinoam; 1988 Mar 30; 18(2):87-96. PubMed ID: 3075109
    [Abstract] [Full Text] [Related]

  • 13. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
    Goldstein JL, Howard KB, Walton SM, McLaughlin TP, Kruzikas DT.
    Clin Gastroenterol Hepatol; 2006 Nov 30; 4(11):1337-45. PubMed ID: 17088110
    [Abstract] [Full Text] [Related]

  • 14. [De-nol in NSAID-induced gastroduodenal lesions].
    Cataldo MG, D'Aiuto A, Bongiorno A.
    Minerva Dietol Gastroenterol; 1990 Nov 30; 36(1):27-30. PubMed ID: 2186304
    [Abstract] [Full Text] [Related]

  • 15. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
    Bianchi Porro G, Lazzaroni M, Petrillo M, Manzionna G, Montrone F, Caruso I.
    Ital J Gastroenterol Hepatol; 1998 Feb 30; 30(1):43-7. PubMed ID: 9615264
    [Abstract] [Full Text] [Related]

  • 16. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C, Pelosini I.
    Ital J Gastroenterol Hepatol; 1999 Feb 30; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [Abstract] [Full Text] [Related]

  • 17. Gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
    Festen HP.
    Neth J Med; 1989 Dec 30; 35(5-6):327-33. PubMed ID: 2699655
    [Abstract] [Full Text] [Related]

  • 18. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
    McCarthy DM.
    J Clin Gastroenterol; 1990 Dec 30; 12 Suppl 2():S13-20. PubMed ID: 1978842
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy of antihelicobacter therapy in NSAID-induced gastropathies].
    Karateev AE, Murav'ev IuV, Radenska-Lopovok SG, Nasonova VA.
    Klin Med (Mosk); 2003 Dec 30; 81(8):37-41. PubMed ID: 14520944
    [Abstract] [Full Text] [Related]

  • 20. Prevention of NSAID-induced GI mucosal injury.
    Gerritz S, Newton WP.
    J Fam Pract; 1997 Feb 30; 44(2):130-1. PubMed ID: 9040509
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.